EDISON, N.J., Sept. 16, 2015 /PRNewswire/ — MTF, the Musculoskeletal Transplant Foundation (www.mtf.org) announced today that beginning October 1, AmnioBand™ Allograft Placental Matrix will be placed in the high-tier reimbursement category for skin substitutes under the Centers for Medicare and Medicaid Services’ (CMS) Hospital